A Cluster Randomized Pilot Trial of a Tailored Worksite Smoking Cessation Intervention Targeting Hispanic/Latino Construction Workers: Intervention Development and Research Design
Overview
Authors
Affiliations
Construction workers have the highest smoking rate among all occupations (39%). Hispanic/Latino workers constitute a large and increasing group in the US construction industry (over 2.6 million; 23% of all workers). These minority workers have lower cessation rates compared to other groups due to their limited access to cessation services, and lack of smoking cessation interventions adapted to their culture and work/life circumstances. Formative research was conducted to create an intervention targeting Hispanic/Latino construction workers. This paper describes the intervention development and the design, methods, and data analysis plans for an ongoing cluster pilot two-arm randomized controlled trial comparing an Enhanced Care worksite cessation program to Standard Care. Fourteen construction sites will be randomized to either Enhanced Care or Standard Care and 126 participants (63/arm) will be recruited. In both arms, recruitment and intervention delivery occur around "food trucks" that regularly visit the construction sites. Participants at Enhanced Care sites will receive the developed intervention consisting of a single face-to-face group counseling session, 2 phone calls, and a fax referral to Florida tobacco quitline (QL). Participants at Standard Care sites will receive a fax referral to the QL. Both groups will receive eight weeks of nicotine replacement treatment and two follow-up assessments at three and six months. Feasibility outcomes are estimated recruitment yield, barriers to delivering the intervention onsite, and rates of adherence/compliance to the intervention, follow-ups, and QL enrollment. Efficacy outcomes are point-prevalence and prolonged abstinence rates at six month follow-up confirmed by saliva cotinine <15 ng/ml.
Lee D, Lee K, Kim H, Lee Y, Lee M, Lee H Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429938 PMC: 9690047. DOI: 10.3390/ijerph192215220.
Chalela P, McAlister A, Despres C, Munoz E, Sukumaran P, Akopian D JMIR Form Res. 2022; 6(6):e28059.
PMID: 35653173 PMC: 9204570. DOI: 10.2196/28059.
Asfar T, Koru-Sengul T, Annane D, McClure L, Perez A, Antoni M Contemp Clin Trials Commun. 2021; 22:100784.
PMID: 34222709 PMC: 8243289. DOI: 10.1016/j.conctc.2021.100784.
Medina-Ramirez P, Calixte-Civil P, Meltzer L, Brandon K, Martinez U, Sutton S J Med Internet Res. 2020; 22(8):e19389.
PMID: 32795986 PMC: 7455877. DOI: 10.2196/19389.
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe T Cochrane Database Syst Rev. 2019; 6():CD009670.
PMID: 31166007 PMC: 6549450. DOI: 10.1002/14651858.CD009670.pub4.